These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 25853032)

  • 21. Strategies for the induction of immune responses at mucosal surfaces making use of cholera toxin B subunit as immunogen, carrier, and adjuvant.
    Holmgren J; Czerkinsky C; Lycke N; Svennerholm AM
    Am J Trop Med Hyg; 1994; 50(5 Suppl):42-54. PubMed ID: 8203723
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antibody against recombinant heat labile enterotoxin B subunit (rLTB) could block LT binding to ganglioside M1 receptor.
    Salimian J; Salmanian A; Khalesi R; Mohseni M; Moazzeni S
    Iran J Microbiol; 2010 Sep; 2(3):120-7. PubMed ID: 22347560
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Recombinant cholera toxin B subunit and gene fusion proteins for oral vaccination.
    Sanchez J; Johansson S; Löwenadler B; Svennerholm AM; Holmgren J
    Res Microbiol; 1990; 141(7-8):971-9. PubMed ID: 2101488
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Nanoparticulated heat-stable (STa) and heat-labile B subunit (LTB) recombinant toxin improves vaccine protection against enterotoxigenic Escherichia coli challenge in mouse.
    Deng G; Zeng J; Jian M; Liu W; Zhang Z; Liu X; Wang Y
    J Biosci Bioeng; 2013 Feb; 115(2):147-53. PubMed ID: 23040995
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Expression of cholera toxin B subunit in transgenic rice endosperm.
    Oszvald M; Kang TJ; Tomoskozi S; Jenes B; Kim TG; Cha YS; Tamas L; Yang MS
    Mol Biotechnol; 2008 Nov; 40(3):261-8. PubMed ID: 18618297
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Cloning, expression and identification of Escherichia coli LTB gene and Vibrio cholerae CTB gene].
    Xia XP; Yan J; Zhao SF
    Zhejiang Da Xue Xue Bao Yi Xue Ban; 2003 Feb; 32(1):17-20. PubMed ID: 12640703
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Oral MucoRice expressing double-mutant cholera toxin A and B subunits induces toxin-specific neutralising immunity.
    Yuki Y; Tokuhara D; Nochi T; Yasuda H; Mejima M; Kurokawa S; Takahashi Y; Kataoka N; Nakanishi U; Hagiwara Y; Fujihashi K; Takaiwa F; Kiyono H
    Vaccine; 2009 Oct; 27(43):5982-8. PubMed ID: 19665603
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Lincomycin-induced over-expression of mature recombinant cholera toxin B subunit and the holotoxin in Escherichia coli.
    Arimitsu H; Tsukamoto K; Ochi S; Sasaki K; Kato M; Taniguchi K; Oguma K; Tsuji T
    Protein Expr Purif; 2009 Oct; 67(2):96-103. PubMed ID: 19410003
    [TBL] [Abstract][Full Text] [Related]  

  • 29. MucoRice-cholera toxin B-subunit, a rice-based oral cholera vaccine, down-regulates the expression of α-amylase/trypsin inhibitor-like protein family as major rice allergens.
    Kurokawa S; Nakamura R; Mejima M; Kozuka-Hata H; Kuroda M; Takeyama N; Oyama M; Satoh S; Kiyono H; Masumura T; Teshima R; Yuki Y
    J Proteome Res; 2013 Jul; 12(7):3372-82. PubMed ID: 23763241
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Persistence and degradation of maize-expressed vaccine protein, Escherichia coli heat-labile enterotoxin subunit B, in soil and water.
    Kosaki H; Coats JR; Wang K; Wolt JD
    Environ Toxicol Chem; 2008 Jun; 27(6):1227-36. PubMed ID: 18198938
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparative whole-genome and proteomics analyses of the next seed bank and the original master seed bank of MucoRice-CTB 51A line, a rice-based oral cholera vaccine.
    Sasou A; Yuki Y; Honma A; Sugiura K; Kashima K; Kozuka-Hata H; Nojima M; Oyama M; Kurokawa S; Maruyama S; Kuroda M; Tanoue S; Takamatsu N; Fujihashi K; Goto E; Kiyono H
    BMC Genomics; 2021 Jan; 22(1):59. PubMed ID: 33468052
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Expression of a cholera toxin B subunit-neutralizing epitope of the porcine epidemic diarrhea virus fusion gene in transgenic lettuce (Lactuca sativa L.).
    Huy NX; Yang MS; Kim TG
    Mol Biotechnol; 2011 Jul; 48(3):201-9. PubMed ID: 21153716
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Protective immunity against Naegleria fowleri infection on mice immunized with the rNfa1 protein using mucosal adjuvants.
    Lee J; Yoo JK; Sohn HJ; Kang HK; Kim D; Shin HJ; Kim JH
    Parasitol Res; 2015 Apr; 114(4):1377-85. PubMed ID: 25604672
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Production of Chicken Egg Yolk Antibody (IgY) Against Recombinant Cholera Toxin B Subunit and Evaluation of Its Prophylaxis Potency in Mice.
    Barati B; Ebrahimi F; Nazarian S
    Iran J Immunol; 2018 Mar; 15(1):47-58. PubMed ID: 29549232
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Good manufacturing practices production of a purification-free oral cholera vaccine expressed in transgenic rice plants.
    Kashima K; Yuki Y; Mejima M; Kurokawa S; Suzuki Y; Minakawa S; Takeyama N; Fukuyama Y; Azegami T; Tanimoto T; Kuroda M; Tamura M; Gomi Y; Kiyono H
    Plant Cell Rep; 2016 Mar; 35(3):667-79. PubMed ID: 26661780
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Construction and preclinical evaluation of recombinant Peru-15 expressing high levels of the cholera toxin B subunit as a vaccine against enterotoxigenic Escherichia coli.
    Roland KL; Cloninger C; Kochi SK; Thomas LJ; Tinge SA; Rouskey C; Killeen KP
    Vaccine; 2007 Dec; 25(51):8574-84. PubMed ID: 18045752
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Broadly protective immunity against divergent influenza viruses by oral co-administration of Lactococcus lactis expressing nucleoprotein adjuvanted with cholera toxin B subunit in mice.
    Lei H; Peng X; Jiao H; Zhao D; Ouyang J
    Microb Cell Fact; 2015 Aug; 14():111. PubMed ID: 26242406
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Robust gut associated vaccine-specific antibody-secreting cell responses are detected at the mucosal surface of Bangladeshi subjects after immunization with an oral killed bivalent V. cholerae O1/O139 whole cell cholera vaccine: comparison with other mucosal and systemic responses.
    Shamsuzzaman S; Ahmed T; Mannoor K; Begum YA; Bardhan PK; Sack RB; Sack DA; Svennerholm AM; Holmgren J; Qadri F
    Vaccine; 2009 Feb; 27(9):1386-92. PubMed ID: 19146897
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Clone and express ctb-stx2b fusion gene in Enterohemrrhagic escherichia coli O157:H7 Shigeal toxin 2B subunit and V cholera toxin B subunit and the detection of their immunogenicity].
    Li ZJ; Sun QZ; Jing HQ; Xu JG
    Zhonghua Liu Xing Bing Xue Za Zhi; 2008 Apr; 29(4):378-82. PubMed ID: 18843998
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Expression and secretion of cholera toxin B subunit in lactobacilli.
    Okuno T; Kashige N; Satho T; Irie K; Hiramatsu Y; Sharmin T; Fukumitsu Y; Uyeda S; Yamada S; Harakuni T; Miyata T; Arakawa T; Imoto M; Toda A; Nakashima Y; Miake F
    Biol Pharm Bull; 2013; 36(6):952-8. PubMed ID: 23727916
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.